Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KOOL NYSEARCA:MVFD BATS:PBL NASDAQ:TUGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKOOLCesca Therapeutics$12.06+0.9%$2.78$2.10▼$7.00$29.14M1.07112,188 shs1,311 shsMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETF$26.08-1.3%$25.73$22.32▼$28.13$70.94M0.7612,083 shs5,894 shsPBLPGIM Portfolio Ballast ETF$29.82+4.9%$28.90$21.18▼$31.19$60.50M0.715,272 shs231 shsTUGNSTF Tactical Growth & Income ETF$24.89+0.2%$24.08$18.60▼$25.36$67.20M-0.8518,618 shs7,218 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKOOLCesca Therapeutics+0.24%+1.19%+5.51%+21.17%+11.72%MVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETF+0.92%+1.93%+3.00%+8.19%+4.68%PBLPGIM Portfolio Ballast ETF+0.27%+0.99%+3.38%+9.23%+2.85%TUGNSTF Tactical Growth & Income ETF-0.76%-0.06%+3.72%+18.01%+1.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKOOLCesca TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/AN/AN/AN/AN/AN/AN/AN/APBLPGIM Portfolio Ballast ETFN/AN/AN/AN/AN/AN/AN/AN/ATUGNSTF Tactical Growth & Income ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKOOLCesca Therapeutics 0.00N/AN/AN/AMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETF 2.54Moderate Buy$26.08N/APBLPGIM Portfolio Ballast ETF 0.00N/AN/AN/ATUGNSTF Tactical Growth & Income ETF 2.76Moderate Buy$24.89N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKOOLCesca Therapeutics$9.67M3.01N/AN/A$3.11 per share3.88MVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/AN/AN/AN/AN/AN/APBLPGIM Portfolio Ballast ETFN/AN/AN/AN/AN/AN/ATUGNSTF Tactical Growth & Income ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKOOLCesca Therapeutics-$39.72M-$3.60N/A1,206.20N/A-98.84%-77.30%-37.75%N/AMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/AN/A0.00∞N/AN/AN/AN/AN/APBLPGIM Portfolio Ballast ETFN/AN/A0.00∞N/AN/AN/AN/AN/ATUGNSTF Tactical Growth & Income ETFN/AN/A32.38∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKOOLCesca TherapeuticsN/A0.50%N/AN/AN/AMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETF$0.391.50%N/AN/AN/APBLPGIM Portfolio Ballast ETF$1.946.51%N/AN/AN/ATUGNSTF Tactical Growth & Income ETF$2.8111.29%N/AN/AN/ALatest PBL, TUGN, MVFD, and KOOL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/22/2025TUGNSTF Tactical Growth & Income ETF$0.24867/23/20257/23/20257/24/20256/24/2025TUGNSTF Tactical Growth & Income ETFMonthly$0.239211.91%6/25/20256/25/20256/26/20255/20/2025TUGNSTF Tactical Growth & Income ETF$0.23525/21/20255/21/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKOOLCesca Therapeutics0.501.520.91MVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/AN/AN/APBLPGIM Portfolio Ballast ETFN/AN/AN/ATUGNSTF Tactical Growth & Income ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKOOLCesca Therapeutics3.11%MVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/APBLPGIM Portfolio Ballast ETFN/ATUGNSTF Tactical Growth & Income ETFN/AInsider OwnershipCompanyInsider OwnershipKOOLCesca Therapeutics68.90%MVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/APBLPGIM Portfolio Ballast ETFN/ATUGNSTF Tactical Growth & Income ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKOOLCesca Therapeutics532.42 millionN/ANot OptionableMVFDNorthern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETFN/A2.72 millionN/AN/APBLPGIM Portfolio Ballast ETFN/A2.14 millionN/ANot OptionableTUGNSTF Tactical Growth & Income ETFN/A2.70 millionN/ANot OptionablePBL, TUGN, MVFD, and KOOL HeadlinesRecent News About These CompaniesHennessy Advisors Inc to acquire two ETFs from STF ManagementMarch 14, 2025 | msn.com(TUGN) Trading SignalsJanuary 28, 2025 | news.stocktradersdaily.comNHow the (TUGN) price action is used to our AdvantageJanuary 18, 2025 | news.stocktradersdaily.comNHow the (TUGN) price action is used to our AdvantageJanuary 18, 2025 | news.stocktradersdaily.comNHow to Take Advantage of moves in (TUGN)December 7, 2024 | news.stocktradersdaily.comN(TUGN) On The My Stocks PageNovember 15, 2024 | news.stocktradersdaily.comNWhere are the Opportunities in (TUGN)November 4, 2024 | news.stocktradersdaily.comNTrading (TUGN) With Integrated Risk ControlsOctober 25, 2024 | news.stocktradersdaily.comNDonoghue Forlines Tactical Income COctober 22, 2024 | morningstar.comM(TUGN) Pivots Trading Plans and Risk ControlsOctober 4, 2024 | news.stocktradersdaily.comNAmplify CWP International Enhanced Dividend Income ETF (IDVO)September 28, 2024 | finance.yahoo.com(TUGN) Investment AnalysisSeptember 12, 2024 | news.stocktradersdaily.comNNorth Square Tactical Growth IAugust 25, 2024 | morningstar.comMTBFG: 1-Stop Shop In An ETFAugust 16, 2024 | seekingalpha.comHCMSX HCM Tactical Growth Fund RetirementAugust 14, 2024 | seekingalpha.comHilton Tactical Income InstlAugust 7, 2024 | morningstar.comMMeeder Tactical Income InstitutionalAugust 3, 2024 | morningstar.comMBTS Tactical Fixed Income CJuly 31, 2024 | morningstar.comMCounterpoint Tactical Income IJuly 26, 2024 | morningstar.comMObjective long/short (TUGN) ReportJuly 25, 2024 | news.stocktradersdaily.comNMedia Sentiment Over TimePBL, TUGN, MVFD, and KOOL Company DescriptionsCesca Therapeutics NASDAQ:KOOLCesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.Northern Lights Fund Trust IV - Monarch Volume Factor Dividend Tree Index ETF NYSEARCA:MVFD$26.08 -0.34 (-1.29%) As of 04:10 PM EasternThe Monarch Volume Factor Dividend Tree Index ETF (MVFD) is an exchange-traded fund that is based on the Monarch Volume Factor Dividend Tree index. The fund tracks an equal-weighted index comprised of US equities that are exhibiting positive cash flow and dividend-paying capabilities. The fund can toggle to short-term US Treasury securities when cash flow trend is negative. MVFD was launched on Mar 6, 2024 and is issued by Monarch.PGIM Portfolio Ballast ETF BATS:PBL$29.82 +1.38 (+4.87%) Closing price 03:03 PM EasternExtended Trading$29.82 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The PGIM Portfolio Ballast ETF (PBL) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund actively manages a portfolio of derivatives, toggling exposure between US large-cap equities and US Treasuries. The fund aims to provide long-term capital growth while limiting downside losses PBL was launched on Dec 12, 2022 and is managed by PGIM.STF Tactical Growth & Income ETF NASDAQ:TUGN$24.89 +0.06 (+0.24%) Closing price 03:59 PM EasternExtended Trading$24.88 -0.01 (-0.04%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The STF Tactical Growth & Income ETF (TUGN) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an actively managed fund that allocates among equities, fixed income, and money markets, depending on signals derived from a proprietary algo that tracks the price action across asset classes. The fund employs an option spread strategy to potentially increase the funds returns TUGN was launched on May 19, 2022 and is managed by STF. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Alphabet’s Breakout Quarter Signals a New Leadership Phase Tesla Just Hit a Fork in the Road—Could the Bulls Lose Control? GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name? Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
